{"id":"https://openalex.org/W2136708520","doi":"https://doi.org/10.1158/2326-6066.cir-15-0073","title":"Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model","display_name":"Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-01","ids":{"openalex":"https://openalex.org/W2136708520","doi":"https://doi.org/10.1158/2326-6066.cir-15-0073","mag":"2136708520","pmid":"https://pubmed.ncbi.nlm.nih.gov/26056145"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-15-0073","doi":"https://doi.org/10.1158/2326-6066.cir-15-0073","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-15-0073","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2136708520"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5115695525","display_name":"Lei Wang","orcid":"https://orcid.org/0000-0002-7067-3732","observed_orcids":["https://orcid.org/0000-0002-7067-3732","https://orcid.org/0009-0003-9890-8948"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lei Wang","raw_affiliation_strings":["1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040715170","display_name":"Zohreh Amoozgar","orcid":"https://orcid.org/0000-0001-8285-8024","observed_orcids":["https://orcid.org/0000-0001-8285-8024"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zohreh Amoozgar","raw_affiliation_strings":["1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042576995","display_name":"Jing Huang","orcid":"https://orcid.org/0000-0002-0814-838X","observed_orcids":["https://orcid.org/0000-0002-0814-838X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jing Huang","raw_affiliation_strings":["1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083245896","display_name":"Mohammad H. Saleh","orcid":"https://orcid.org/0000-0002-2375-0416","observed_orcids":["https://orcid.org/0000-0002-2375-0416"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mohammad H. Saleh","raw_affiliation_strings":["1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060218660","display_name":"Deyin Xing","orcid":"https://orcid.org/0000-0002-0515-4194","observed_orcids":["https://orcid.org/0000-0002-0515-4194"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Deyin Xing","raw_affiliation_strings":["2Department of Pathology, Johns Hopkins University, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Pathology, Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075368929","display_name":"Sandra Or\u0161uli\u0107","orcid":"https://orcid.org/0000-0001-5119-8721","observed_orcids":["https://orcid.org/0000-0001-5119-8721"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandra Orsulic","raw_affiliation_strings":["3Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088140942","display_name":"Michael S. Goldberg","orcid":"https://orcid.org/0000-0003-1450-7606","observed_orcids":["https://orcid.org/0000-0003-1450-7606"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael S. Goldberg","raw_affiliation_strings":["1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.5934,"has_fulltext":false,"cited_by_count":181,"citation_normalized_percentile":{"value":0.98315197,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"3","issue":"9","first_page":"1030","last_page":"1041"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.05550000071525574,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":1.0},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8320000171661377},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.8610000014305115},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9800000190734863},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8389999866485596},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.699999988079071},{"id":"https://openalex.org/keywords/lymphocyte-trafficking","display_name":"lymphocyte migration","score":0.781000018119812},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":0.8830000162124634},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.699999988079071},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/t-cell-differentiation","display_name":"T cell differentiation","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cytotoxic-lymphocytes","display_name":"cytotoxic lymphocytes","score":0.796999990940094},{"id":"https://openalex.org/keywords/drug-resistant-cancer","display_name":"drug-resistant cancer","score":0.5550000071525574},{"id":"https://openalex.org/keywords/syngeneic-murine-model","display_name":"syngeneic murine model","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7238372564315796},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6418845653533936},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.5784984230995178},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5662925839424133},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5556928515434265},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5411478877067566},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5263596773147583},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5119067430496216},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.49235546588897705},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.48535552620887756},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.48281535506248474},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4583096504211426},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4230271279811859},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.41723763942718506},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.41520634293556213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.31168460845947266},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26272135972976685},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1754828691482544},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.12516069412231445},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.07558557391166687},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07553201913833618},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077209","descriptor_name":"Decitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001202","descriptor_name":"Ascitic Fluid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002471","descriptor_name":"Cell Transformation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002471","descriptor_name":"Cell Transformation, Neoplastic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008198","descriptor_name":"Lymph Nodes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1158/2326-6066.cir-15-0073","doi":"https://doi.org/10.1158/2326-6066.cir-15-0073","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-15-0073","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"pmid:26056145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26056145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.922.2497","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.922.2497","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerimmunolres.aacrjournals.org/content/early/2015/08/12/2326-6066.CIR-15-0073.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.927.2925","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.927.2925","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerimmunolres.aacrjournals.org/content/3/9/1030.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324787","display_name":"Peking University","ror":"https://ror.org/02v51f717"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1484356204","https://openalex.org/W1503744211","https://openalex.org/W1827923022","https://openalex.org/W1943545698","https://openalex.org/W1965205681","https://openalex.org/W1967889234","https://openalex.org/W1977222310","https://openalex.org/W1983149123","https://openalex.org/W1985328622","https://openalex.org/W1994932725","https://openalex.org/W1996843158","https://openalex.org/W1996933935","https://openalex.org/W1999539710","https://openalex.org/W2003230562","https://openalex.org/W2016849135","https://openalex.org/W2022952467","https://openalex.org/W2022991465","https://openalex.org/W2028525364","https://openalex.org/W2030131197","https://openalex.org/W2044835625","https://openalex.org/W2065779257","https://openalex.org/W2079707111","https://openalex.org/W2080016709","https://openalex.org/W2085208565","https://openalex.org/W2085284176","https://openalex.org/W2090912134","https://openalex.org/W2094419175","https://openalex.org/W2096322385","https://openalex.org/W2098337213","https://openalex.org/W2101653483","https://openalex.org/W2104764745","https://openalex.org/W2105459360","https://openalex.org/W2105657402","https://openalex.org/W2106391833","https://openalex.org/W2113225141","https://openalex.org/W2116991842","https://openalex.org/W2117692326","https://openalex.org/W2120427304","https://openalex.org/W2121080857","https://openalex.org/W2134069241","https://openalex.org/W2135025419","https://openalex.org/W2138899068","https://openalex.org/W2141410747","https://openalex.org/W2142263069","https://openalex.org/W2147516356","https://openalex.org/W2160410413","https://openalex.org/W2161489839","https://openalex.org/W2162222767","https://openalex.org/W2168530155","https://openalex.org/W2171297632"],"related_works":["https://openalex.org/W4386748243","https://openalex.org/W4388495293","https://openalex.org/W2616605961","https://openalex.org/W2944277341","https://openalex.org/W4313383324","https://openalex.org/W4232800316","https://openalex.org/W2085208565","https://openalex.org/W3165432298","https://openalex.org/W1414458693"],"abstract_inverted_index":{"The":[0],"lack":[1],"of":[2,12,60,72,96,109,117,142,154,182,188],"second-line":[3],"treatment":[4,92,187],"for":[5,185],"relapsed":[6],"ovarian":[7,64,87,190],"cancer":[8,29,88],"necessitates":[9],"the":[10,69,94,115,140],"development":[11],"improved":[13,186],"combination":[14,39,147,151,177],"therapies.":[15],"Targeted":[16],"therapy":[17,43,178],"and":[18,102,111,113,162],"immunotherapy":[19],"each":[20],"confer":[21],"clinical":[22],"benefit,":[23],"albeit":[24],"limited":[25],"as":[26,134,167,169],"monotherapies.":[27],"Ovarian":[28],"is":[30],"not":[31],"particularly":[32],"responsive":[33],"to":[34],"immune":[35,128],"checkpoint":[36,129],"blockade,":[37],"so":[38],"with":[40,148],"a":[41,52,73,84,135],"complementary":[42],"may":[44,179],"be":[45,180],"beneficial.":[46],"Recent":[47],"studies":[48],"have":[49],"revealed":[50],"that":[51,98,175],"DNA":[53,75],"methyl":[54,76],"transferase":[55,77],"inhibitor,":[56,78],"azacytidine,":[57],"alters":[58],"expression":[59,95],"immunoregulatory":[61],"genes":[62],"in":[63,83,137],"cancer.":[65,191],"In":[66],"this":[67,138,176],"study,":[68],"antitumor":[70],"effects":[71],"related":[74],"decitabine":[79],"(DAC),":[80],"were":[81],"demonstrated":[82],"syngeneic":[85],"murine":[86],"model.":[89],"Low-dose":[90],"DAC":[91,126],"increases":[93],"chemokines":[97],"recruit":[99],"NK":[100],"cells":[101,157,161],"CD8(+)":[103],"T":[104,156,160],"cells,":[105],"promotes":[106,152],"their":[107],"production":[108],"IFN\u03b3":[110],"TNF\u03b1,":[112],"extends":[114],"survival":[116],"mice":[118],"bearing":[119],"subcutaneous":[120],"or":[121],"orthotopic":[122],"tumors.":[123],"While":[124],"neither":[125],"nor":[127],"blockade":[130],"confers":[131],"durable":[132],"responses":[133,166],"monotherapy":[136],"model,":[139],"efficacy":[141],"anti-CTLA-4":[143],"was":[144],"potentiated":[145],"by":[146],"DAC.":[149],"This":[150],"differentiation":[153],"na\u00efve":[155],"into":[158],"effector":[159],"prolongs":[163],"cytotoxic":[164],"lymphocyte":[165],"well":[168],"mouse":[170],"survival.":[171],"These":[172],"results":[173],"suggest":[174],"worthy":[181],"further":[183],"consideration":[184],"drug-resistant":[189]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2136708520","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":23},{"year":2021,"cited_by_count":23},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
